Steven A. Ledger - Sep 9, 2024 Form 4 Insider Report for Serina Therapeutics, Inc. (SER)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	SER	Stock Option (right to buy)	Award	$0	+376K	+330.28%	$0.00	490K	Sep 9, 2024	Common Stock	376K	$7.40	Direct	F1

Showing 1 to 1 of 1 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	The stock options vest as to 12.5% of the underlying shares on March 9, 2025 and thereafter in substantially equal monthly installments such that the stock options shall be fully vested on the fourth anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.